| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_2e8ccc7e1204c0b5d34249316c40c07a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_fc6a0414319cae8b55236b95a3cfe561
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_b6042509de7544921c96de43b9da1438
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ad27359ecac3e734ddf96cf52956d386 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y10T29-49826
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0039 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61F13-26
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M31-002
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P19-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P15-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P15-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61F6-144
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P13-00 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61F6-14 |
| filingDate |
2010-05-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5aa928af32671364fadc3f8f1df79190
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d4875512d0447748be14c8bed56aed0a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ab65773c5d5b7b223a360a34401518d5 |
| publicationDate |
2010-11-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2010128004-A1 |
| titleOfInvention |
Intrauterine system for use in medical treatment |
| abstract |
An intrauterine system (1) is disclosed for use in the treatment of dysfunctional uterine bleeding; menorraghia; dysmenorrhoea; endometriosis; uterine fibroids; climacteric complaints; osteoporosis; and urogenital atrophy. The system is formed by a frame (16) defining an interior space (20) for receipt of a deposit (22) of a therapeutically effective dose of a biologically active compound. The frame has an open structure allowing access to a substantial part of an outer surface of the deposit, and the deposit has a rate controlling structure (26) that controls a rate of release of the compound within the uterus. One or more retention elements (6) are provided on the frame for retaining the frame within the uterus of a female mammal. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2014090976-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-3827797-A4
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/FR-3078486-A1 |
| priorityDate |
2009-05-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |